232 related articles for article (PubMed ID: 2780747)
1. Medical management of beta-thalassemia.
Lerner N
Prog Clin Biol Res; 1989; 309():13-22. PubMed ID: 2780747
[No Abstract] [Full Text] [Related]
2. Cardiac complications in homozygous beta-thalassemia.
Wonke B; Hoffbrand AV; Aldouri MA; Ward SE
Prog Clin Biol Res; 1989; 309():51-6. PubMed ID: 2780750
[No Abstract] [Full Text] [Related]
3. Clinical management of beta-thalassemia.
Graziano J; Piomelli S
Tex Rep Biol Med; 1980-1981; 40():355-64. PubMed ID: 7034276
[No Abstract] [Full Text] [Related]
4. Quality of life and life expectancy in thalassemic patients with complications.
Gabutti V; Piga A; Sacchetti L; Sandri A; Biginelli M; Saracco P; Ferri M
Prog Clin Biol Res; 1989; 309():35-41. PubMed ID: 2780748
[No Abstract] [Full Text] [Related]
5. Advances in the use of iron-chelating agents for the treatment of iron overload.
Modell B
Prog Hematol; 1979; 11():267-312. PubMed ID: 392593
[No Abstract] [Full Text] [Related]
6. High-dose intravenous chelation therapy with deferoxamine.
Cohen A; Mizanin J; Schwartz E
Prog Clin Biol Res; 1989; 309():125-31. PubMed ID: 2780746
[No Abstract] [Full Text] [Related]
7. [Serum ferritin in the follow-up of homozygotic beta-thalassemia treated with blood transfusion and iron-chelating agents].
Esposito L; Ferrara M; Ponte G
Pediatria (Napoli); 1981 Sep; 89(3):479-92. PubMed ID: 7346759
[No Abstract] [Full Text] [Related]
8. Measurement of iron status.
Pippard MJ
Prog Clin Biol Res; 1989; 309():85-92. PubMed ID: 2675108
[No Abstract] [Full Text] [Related]
9. Compliance with therapy in Cooley's anaemia.
Vullo C; Di Palma A
Prog Clin Biol Res; 1989; 309():43-9. PubMed ID: 2780749
[No Abstract] [Full Text] [Related]
10. Hepatic iron stores in thalassemia: non-invasive magnetic measurements.
Brittenham GM; Allen CJ; Farrell DE; Harris JW
Prog Clin Biol Res; 1989; 309():101-6. PubMed ID: 2780744
[No Abstract] [Full Text] [Related]
11. [Chelating therapy in beta-thalassemia].
Musumeci S; Romeo MA; Di Gregorio F; Schiliró G; Russo G
Pediatr Med Chir; 1982; 4(1-2):55-9. PubMed ID: 7111040
[TBL] [Abstract][Full Text] [Related]
12. Iron chelation.
Hershko C; Link G; Pinson A
Prog Clin Biol Res; 1989; 309():133-40. PubMed ID: 2675082
[No Abstract] [Full Text] [Related]
13. Outcomes, utilization, and costs among thalassemia and sickle cell disease patients receiving deferoxamine therapy in the United States.
Delea TE; Hagiwara M; Thomas SK; Baladi JF; Phatak PD; Coates TD
Am J Hematol; 2008 Apr; 83(4):263-70. PubMed ID: 17924547
[TBL] [Abstract][Full Text] [Related]
14. Reduction of iron overload in thalassemia.
Piomelli S; Graziano J
Birth Defects Orig Artic Ser; 1982; 18(7):339-46. PubMed ID: 7159742
[No Abstract] [Full Text] [Related]
15. Chelation therapy and ferritin levels in patients with homozygous beta-thalassemia.
Kattamis C; Lagos P; Langona E
Prog Clin Biol Res; 1979; 34():351-9. PubMed ID: 531060
[No Abstract] [Full Text] [Related]
16. Liver iron stores before and after bone marrow transplantation for thalassemia.
Politi P; Lucarelli G; Capriotti L; Salvadori P; Dardanelli C; Barbanti I
Prog Clin Biol Res; 1989; 309():281-9. PubMed ID: 2675096
[No Abstract] [Full Text] [Related]
17. [The endocrine complications in thalassemia major].
Anastasi S; Caruso V; Magnano C; Leocata A
Pediatr Med Chir; 1991; 13(1):63-5. PubMed ID: 2052458
[TBL] [Abstract][Full Text] [Related]
18. Endocrine complications in thalassaemia major.
De Sanctis V; Vullo C; Katz M; Wonke B; Hoffbrand VA; Di Palma A; Bagni B
Prog Clin Biol Res; 1989; 309():77-83. PubMed ID: 2780752
[No Abstract] [Full Text] [Related]
19. Oral iron chelators.
Nathan DG; Piomelli S
Semin Hematol; 1990 Apr; 27(2):83-5. PubMed ID: 2190320
[No Abstract] [Full Text] [Related]
20. Transfusion haemosiderosis and chelation therapy.
Ley TJ; Griffith P; Nienhuis AW
Clin Haematol; 1982 Jun; 11(2):437-64. PubMed ID: 7042160
[No Abstract] [Full Text] [Related]
[Next] [New Search]
